🇺🇸 FDA
Patent

US 12215138

Compositions and methods for internalizing enzymes

granted A61KA61K38/47A61K48/00

Quick answer

US patent 12215138 (Compositions and methods for internalizing enzymes) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K38/47, A61K48/00, A61P, A61P43/00